GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Cash Flow from Investing

Shandong Boan Biotechnology Co (HKSE:06955) Cash Flow from Investing : HK$-321.1 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2023, Shandong Boan Biotechnology Co spent HK$6.3 Mil on purchasing property, plant, equipment. It gained HK$0.0 Mil from selling property, plant, and equipment. It spent HK$0.0 Mil on purchasing business. It gained HK$0.0 Mil from selling business. It spent HK$0.0 Mil on purchasing investments. It gained HK$0.0 Mil from selling investments. It paid HK$160.1Mil for net Intangibles purchase and sale. And it received HK$0.1 Mil from other investing activities. In all, Shandong Boan Biotechnology Co spent HK$166.2 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2023.


Shandong Boan Biotechnology Co Cash Flow from Investing Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Cash Flow from Investing Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
-22.27 -529.33 -112.44 -321.10

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Investing Get a 7-Day Free Trial -210.70 -114.41 -3.44 -154.86 -166.24

Shandong Boan Biotechnology Co Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Shandong Boan Biotechnology Co's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

Shandong Boan Biotechnology Co's Cash Flow from Investing for the quarter that ended in Dec. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-321.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Boan Biotechnology Co  (HKSE:06955) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Shandong Boan Biotechnology Co's purchase of property, plant, equipment for the six months ended in Dec. 2023 was HK$-6.3 Mil. It means Shandong Boan Biotechnology Co spent HK$6.3 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Shandong Boan Biotechnology Co's sale of property, plant, equipment for the six months ended in Dec. 2023 was HK$0.0 Mil. It means Shandong Boan Biotechnology Co gained HK$0.0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Shandong Boan Biotechnology Co's purchase of business for the six months ended in Dec. 2023 was HK$0.0 Mil. It means Shandong Boan Biotechnology Co spent HK$0.0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Shandong Boan Biotechnology Co's sale of business for the six months ended in Dec. 2023 was HK$0.0 Mil. It means Shandong Boan Biotechnology Co gained HK$0.0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Shandong Boan Biotechnology Co's purchase of investment for the six months ended in Dec. 2023 was HK$0.0 Mil. It means Shandong Boan Biotechnology Co spent {stock_data.stock.currency_symbol}}0.0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Shandong Boan Biotechnology Co's sale of investment for the six months ended in Dec. 2023 was HK$0.0 Mil. It means Shandong Boan Biotechnology Co gained HK$0.0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Shandong Boan Biotechnology Co's net Intangibles purchase and sale for the six months ended in Dec. 2023 was HK$-160.1 Mil. It means Shandong Boan Biotechnology Co paid HK$160.1 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Shandong Boan Biotechnology Co's cash from discontinued investing activities for the six months ended in Dec. 2023 was 0.0 Mil. It means Shandong Boan Biotechnology Co paid HK$0.0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Shandong Boan Biotechnology Co's cash from other investing activities for the six months ended in Dec. 2023 was HK$0.1 Mil. It means Shandong Boan Biotechnology Co received HK$0.1 Mil from other investing activities.


Shandong Boan Biotechnology Co Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines